Top

Published in:

01-06-2014 | Original Article

Prognostic value of c-FLIP_L/s, HIF-1α, and NF-κβ in stage II and III rectal cancer

Authors: Anna Novell, Montserrat Martínez-Alonso, Moises Mira, Jordi Tarragona, Antonieta Salud, Xavier Matias-Guiu

Published in: Virchows Archiv | Issue 6/2014

Abstract

Locally advanced rectal cancer (LARC) is associated with a 25 % rate of metastases. The prognostic and predictive relevances of the expression of five proteins (c-FLIP_L/s, HIF-1α, β-catenin, p65, and p105/p50 NF-κβ) were assessed. This is a retrospective study. From 1998 to 2009, 152 patients with stage II/III rectal cancer were treated with radio-chemotherapy. TMAs constructed with tumor and normal tissue from the diagnostic endoscopic biopsy and the surgical specimen after chemoradiotherapy were subjected to immunohistochemical (IHC) analysis. Results were correlated with clinical and pathological data, including progression-free survival (PFS). Four different IHC conditions were independent prognostic parameters for PFS: (1) cytoplasmic c-FLIP_L/s (p = 0.007), (2) nuclear HIF-1α (p = 0.020), (3) a change in the cytoplasmic p65 between the diagnostic biopsy and the post-treatment specimen (p = 0.004), and (4) a change in the cytoplasmic c-FLIP_L/s between the diagnostic biopsy and the post-treatment specimen (p = 0.021). Three different protein expression profiles, combining biomarkers, showed prognostic significance. IHC evaluation of these biomarkers in our three protein expression profiles may help to identify patients with worse prognosis and design more effective therapeutic strategies to personalize the treatment of rectal cancer.

Baba Y, Nosho K, Shima K, Irahara N, Chan AT, Meyerhardt JA, Chung DC, Giovannucci EL, Fuchs CS, Ogino S (2010) HIF1A overexpression is associated with poor prognosis in a cohort of 731 colorectal cancers. Am J Pathol 176:2292–2301PubMedCentralPubMedCrossRef

Ben Lassoued A, Beaufils N, Dales JP, Gabert J (2013) Hypoxia-inducible factor-1alpha as prognostic marker. Expert Opin Med Diagn 7:53–70. doi:10.1517/17530059.2012.719022 PubMedCrossRef

Bosman FT, Carneiro F, Hruban RH, Theise ND (2010) WHO classification of tumors of the digestive system.

Brennan DJ, O'Connor DP, Rexhepaj E, Ponten F, Gallagher WM (2010) Antibody-based proteomics: fast-tracking molecular diagnostics in oncology. Nat Rev Cancer 10:605–617. doi:10.1038/nrc2902 PubMedCrossRef

Dolcet X, Llobet D, Pallares J, Matias-Guiu X (2005) NF-kB in development and progression of human cancer. Virchows Arch 446:475–482. doi:10.1007/s00428-005-1264-9 PubMedCrossRef

Ellis RD, Goodlad JR, Limb GA, Powell JJ, Thompson RP, Punchard NA (1998) Activation of nuclear factor kappa B in Crohn’s disease. Inflamm Res 47:440–445PubMedCrossRef

Evertsson S, Sun XF (2002) Protein expression of NF-kappaB in human colorectal adenocarcinoma. Int J Mol Med 10:547–550PubMed

Ferlay J, Parkin DM, Steliarova-Foucher E (2010) Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer 46:765–781. doi:10.1016/j.ejca.2009.12.014 PubMedCrossRef

Furlan D, Sahnane N, Carnevali I, Cerutti R, Bertoni F, Kwee I, Uccella S, Bertolini V, Chiaravalli AM, Capella C (2008) Up-regulation of the hypoxia-inducible factor-1 transcriptional pathway in colorectal carcinomas. Hum Pathol 39:1483–1494PubMedCrossRef

10.

Gorlach A, Bonello S (2008) The cross-talk between NF-kappaB and HIF-1: further evidence for a significant liaison. Biochem J 412:e17–e19PubMed

11.

Kaidi A, Williams AC, Paraskeva C (2007) Interaction between beta-catenin and HIF-1 promotes cellular adaptation to hypoxia. Nat Cell Biol 9:210–217PubMedCrossRef

12.

Korkolopoulou P, Saetta AA, Levidou G, Gigelou F, Lazaris A, Thymara I, Scliri M, Bousboukea K, Michalopoulos NV, Apostolikas N, Konstantinidou A, Tzivras M, Patsouris E (2007) c-FLIP expression in colorectal carcinomas: association with Fas/FasL expression and prognostic implications. Histopathology 51:150–156PubMedCrossRef

13.

Lee CH, Jeon YT, Kim SH, Song YS (2007) NF-kappaB as a potential molecular target for cancer therapy. Biofactors 29:19–35PubMedCrossRef

14.

Lu XG, Xing CG, Feng YZ, Chen J, Deng C (2006) Clinical significance of immunohistochemical expression of hypoxia-inducible factor-1alpha as a prognostic marker in rectal adenocarcinoma. Clin Colorectal Cancer 5:350–353PubMedCrossRef

15.

Ludwig JA, Weinstein JN (2005) Biomarkers in cancer staging, prognosis and treatment selection. Nat Rev Cancer 5:845–856. doi:10.1038/nrc1739 PubMedCrossRef

16.

Mann B, Gelos M, Siedow A, Hanski ML, Gratchev A, Ilyas M, Bodmer WF, Moyer MP, Riecken EO, Buhr HJ, Hanski C (1999) Target genes of beta-catenin-T cell-factor/lymphoid-enhancer-factor signaling in human colorectal carcinomas. Proc Natl Acad Sci U S A 96:1603–1608PubMedCentralPubMedCrossRef

17.

Micheau O, Lens S, Gaide O, Alevizopoulos K, Tschopp J (2001) NF-kappaB signals induce the expression of c-FLIP. Mol Cell Biol 21:5299–5305. doi:10.1128/mcb.21.16.5299-5305.2001 PubMedCentralPubMedCrossRef

18.

Musio D, De Felice F, Bulzonetti N, Guarnaccia R, Caiazzo R, Bangrazi C, Raffetto N, Tombolini V (2013) Neoadjuvant-intensified treatment for rectal cancer: time to change? World J Gastroenterol 19:3052–3061. doi:10.3748/wjg.v19.i20.3052 PubMedCentralPubMedCrossRef

19.

Naito M, Katayama R, Ishioka T, Suga A, Takubo K, Nanjo M, Hashimoto C, Taira M, Takada S, Takada R, Kitagawa M, Matsuzawa S, Reed JC, Tsuruo T (2004) Cellular FLIP inhibits beta-catenin ubiquitylation and enhances Wnt signaling. Mol Cell Biol 24:8418–8427. doi:10.1128/mcb.24.19.8418-8427.2004 PubMedCentralPubMedCrossRef

20.

Pallares J, Santacana M, Puente S, Lopez S, Yeramian A, Eritja N, Sorolla A, Llobet D, Dolcet X, Matias-Guiu X (2009) A review of the applications of tissue microarray technology in understanding the molecular features of endometrial carcinoma. Anal Quant Cytol Histol 31:217–226PubMed

21.

Rimm DL, Camp RL, Charette LA, Costa J, Olsen DA, Reiss M (2001) Tissue microarray: a new technology for amplification of tissue resources. Cancer J 7:24–31PubMed

22.

Schoenfeld DA (1983) Sample-size formula for the proportional-hazards regression model. Biometrics 39:499–503PubMedCrossRef

23.

Simiantonaki N, Taxeidis M, Jayasinghe C, Kurzik-Dumke U, Kirkpatrick CJ (2008) Hypoxia-inducible factor 1 alpha expression increases during colorectal carcinogenesis and tumor progression. BMC Cancer 8:320PubMedCentralPubMedCrossRef

24.

Thakur R, Mishra DP (2013) Pharmacological modulation of beta-catenin and its applications in cancer therapy. J Cell Mol Med 17:449–456. doi:10.1111/jcmm.12033 PubMedCrossRef

25.

Theodoropoulos GE, Lazaris AC, Theodoropoulos VE, Papatheodosiou K, Gazouli M, Bramis J, Patsouris E, Panoussopoulos D (2006) Hypoxia, angiogenesis and apoptosis markers in locally advanced rectal cancer. Int J Colorectal Dis 21:248–257PubMedCrossRef

26.

Ullenhag GJ, Mukherjee A, Watson NF, Al-Attar AH, Scholefield JH, Durrant LG (2007) Overexpression of FLIPL is an independent marker of poor prognosis in colorectal cancer patients. Clin Cancer Res 13:5070–5075. doi:10.1158/1078-0432.ccr-06-2547 PubMedCrossRef

27.

Valentini V, van Stiphout RG, Lammering G, Gambacorta MA, Barba MC, Bebenek M, Bonnetain F, Bosset JF, Bujko K, Cionini L, Gerard JP, Rodel C, Sainato A, Sauer R, Minsky BD, Collette L, Lambin P (2011) Nomograms for predicting local recurrence, distant metastases, and overall survival for patients with locally advanced rectal cancer on the basis of European randomized clinical trials. J Clin Oncol 29:3163–3172PubMedCrossRef

28.

Voboril R, Voborilova J, Rychterova V, Jirasek T, Dvorak J (2008) Dissociated invasively growing cancer cells with NF-kappaB/p65 positivity after radiotherapy: a new marker for worse clinical outcome in rectal cancer? Preliminary data Clin Exp Metastasis 25:491–496. doi:10.1007/s10585-008-9155-5 CrossRef

29.

Voboril R, Weberova-Voborilova J (2007) Sensitization of colorectal cancer cells to irradiation by IL-4 and IL-10 is associated with inhibition of NF-kappaB. Neoplasma 54:495–502PubMed

30.

Wilson TR, McLaughlin KM, McEwan M, Sakai H, Rogers KM, Redmond KM, Johnston PG, Longley DB (2007) c-FLIP: a key regulator of colorectal cancer cell death. Cancer Res 67:5754–5762PubMedCrossRef

31.

Yu HG, Yu LL, Yang Y, Luo HS, Yu JP, Meier JJ, Schrader H, Bastian A, Schmidt WE, Schmitz F (2003) Increased expression of RelA/nuclear factor-kappa B protein correlates with colorectal tumorigenesis. Oncology 65:37–45. doi:10.1159/000071203

32.

Yu HG, Zhong X, Yang YN, Luo HS, Yu JP, Meier JJ, Schrader H, Bastian A, Schmidt WE, Schmitz F (2004) Increased expression of nuclear factor-kappaB/RelA is correlated with tumor angiogenesis in human colorectal cancer. Int J Colorectal Dis 19:18–22. doi:10.1007/s00384-003-0494-z PubMedCrossRef

Title: Prognostic value of c-FLIPL/s, HIF-1α, and NF-κβ in stage II and III rectal cancer
Authors: Anna Novell
Montserrat Martínez-Alonso
Moises Mira
Jordi Tarragona
Antonieta Salud
Xavier Matias-Guiu
Publication date: 01-06-2014
Publisher: Springer Berlin Heidelberg
Published in: Virchows Archiv / Issue 6/2014
Print ISSN: 0945-6317
Electronic ISSN: 1432-2307
DOI: https://doi.org/10.1007/s00428-014-1572-z

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Prognostic value of c-FLIP_L/s, HIF-1α, and NF-κβ in stage II and III rectal cancer

Abstract

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 6/2014

Absence of estrogen receptor alpha (ESR1) gene amplification in a series of breast cancers in Taiwan

Coronary cardiac allograft vasculopathy versus native atherosclerosis: difficulties in classification

Defined morphological criteria allow reliable diagnosis of colorectal serrated polyps and predict polyp genetics

Invasive breast carcinomas of no special type with osteoclast-like giant cells frequently have a luminal phenotype

Loss of nuclear prothymosin-α expression is associated with disease progression in human superficial bladder cancer

VE1 immunohistochemistry accurately detects BRAF V600E mutations in colorectal carcinoma and can be utilized in the detection of poorly differentiated colorectal serrated adenocarcinoma